Healthcare Stocks To Keep An Eye On – February 04th

Alphabet, Merck & Co., Inc., ServiceNow, Danaher, and Salesforce are the five Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are investments in companies operating within the healthcare sector, including pharmaceutical companies, biotechnology firms, medical device manufacturers, healthcare providers, and healthcare technology companies. These stocks can provide opportunities for investors to participate in the growth and innovation of the healthcare industry, as well as potentially benefit from trends in healthcare spending and advancements in medical research and technology. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Alphabet (GOOGL)

Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube.

Shares of Alphabet stock traded up $3.68 on Tuesday, reaching $204.91. 15,316,208 shares of the company were exchanged, compared to its average volume of 24,662,139. Alphabet has a one year low of $130.66 and a one year high of $206.68. The company has a market capitalization of $2.51 trillion, a price-to-earnings ratio of 27.14, a PEG ratio of 1.31 and a beta of 0.99. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.04. The company has a 50-day moving average of $189.64 and a 200 day moving average of $174.20.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of Merck & Co., Inc. stock traded down $10.15 on Tuesday, reaching $89.65. 31,429,086 shares of the company were exchanged, compared to its average volume of 11,995,411. Merck & Co., Inc. has a one year low of $87.33 and a one year high of $134.63. The company has a market capitalization of $226.77 billion, a price-to-earnings ratio of 18.78, a PEG ratio of 1.20 and a beta of 0.38. The company has a current ratio of 1.36, a quick ratio of 1.15 and a debt-to-equity ratio of 0.79. The company has a 50-day moving average of $99.80 and a 200 day moving average of $107.37.

ServiceNow (NOW)

ServiceNow, Inc. provides end to-end intelligent workflow automation platform solutions for digital businesses in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally. The company operates the Now platform for end-to-end digital transformation, artificial intelligence, machine learning, robotic process automation, process mining, performance analytics, and collaboration and development tools.

NOW traded down $17.60 during trading hours on Tuesday, reaching $1,003.34. The company’s stock had a trading volume of 1,015,864 shares, compared to its average volume of 1,695,988. ServiceNow has a 52 week low of $637.99 and a 52 week high of $1,198.09. The company’s 50-day moving average is $1,083.05 and its 200-day moving average is $959.36. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.10 and a current ratio of 1.10. The firm has a market cap of $206.69 billion, a PE ratio of 146.90, a price-to-earnings-growth ratio of 4.74 and a beta of 0.99.

Danaher (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

DHR traded down $1.23 during trading hours on Tuesday, reaching $213.03. The company’s stock had a trading volume of 3,755,499 shares, compared to its average volume of 3,776,062. Danaher has a 52 week low of $210.04 and a 52 week high of $281.70. The company’s 50-day moving average is $234.93 and its 200-day moving average is $252.88. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm has a market cap of $153.87 billion, a PE ratio of 40.35, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83.

Salesforce (CRM)

Salesforce, Inc. provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide. The company's service includes sales to store data, monitor leads and progress, forecast opportunities, gain insights through analytics and artificial intelligence, and deliver quotes, contracts, and invoices; and service that enables companies to deliver trusted and highly personalized customer support at scale.

CRM traded up $1.64 during trading hours on Tuesday, reaching $340.88. The company’s stock had a trading volume of 2,255,997 shares, compared to its average volume of 6,045,853. Salesforce has a 52 week low of $212.00 and a 52 week high of $369.00. The company’s 50-day moving average is $338.67 and its 200-day moving average is $298.64. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market cap of $326.22 billion, a PE ratio of 56.08, a price-to-earnings-growth ratio of 3.09 and a beta of 1.31.